In contrast to classical ASIC blockers with poor selectivity or blood–brain barrier permeability in drug delivery4,49, LK-2 at low micromolar concentrations preferentially decouples glutamate from ASICs, showing a promising neuroprotective efficacy and neurobehavioural recovery after stroke. The gene discussed is ASIC1; the disease is Stroke.